Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.
She had large B-cell lymphoma — an aggressive cancer diagnosed in 150,000 patients each year globally.
As a doctor, she knew the risk. She got a CAT scan, looked at the images, and her world stopped.
Four years later the lymphoma returned. Robyn’s care team prescribed a further six cycles of a brutal chemotherapy, followed by an autologous stem cell transplant (ASCT) and external beam radiation. Robyn’s ASCT treatment was further complicated by septic shock requiring a stay in intensive care.
Robyn entered remission again, but it was short-lived, with the lymphoma returning nine months later. Treatment options for Robyn were now bleak and limited.
Robyn immediately sought treatment. With her husband by her side, she underwent many rounds of chemotherapy and went into remission.
Feeling defeated, she found a clinical trial for CAR T-cell therapy, a new treatment that reengineers white blood cells to target and eradicate cancer.
She thought this was her last chance.
A week after receiving treatment, her lymph nodes shrunk. Within three months, there was no evidence of the disease.
Today, she’s cancer free — and sharing her experiences to help us better meet the needs of patients like her in our cell and gene therapy trials.
Lives can change when you design cell and gene therapy trials with speed and precision.
Utilize the right experts, focused on the right indications
Access even hard-to-find patient populations
Pinpoint the perfect sites for your trial
Satisfy global regulations, to get your treatment to market safely and quickly
What we do, we do
Our Experts
Our cell and gene therapy specialists collaborate to help get your innovative treatments to patients like Robyn faster.
Vice President, Cell and Gene Therapy, Center of Excellence
With 20+ years of trial execution and team management experience, Chris leads development for our cell and gene therapeutic area. He reinforces our patient-first focus to help ensure your trials are designed to meet patient needs.
"Being able to capture and understand the patient’s perspective — not just as a patient, but as a person — and use their insight to guide my decisions is what it means to work With Heart™."
Our diverse experiences ensure you get the expertise you need, no matter the indication.
Our experience with CAGT clinical trial sites around the world allows us to accelerate study start-ups.
North America
South America
Europe
APAC
Middle East & Africa
Access to global EMR data enables us to pinpoint the perfect sites for your trial.
Our cross-functional team overcomes any technical, logistical, and strategic challenges.
Our highly tailored recruitment and retention strategies drive access to even hard-to-find patient populations.
The perspectives and opinions expressed in this material represent those of the patient advocate only and should not be considered a solicitation, promotion or advertisement for any services of Parexel, or any drugs or therapies, including those under development. Participating in clinical trials for investigational medicines offers patients potential benefits, such as access to cutting-edge treatments and expert medical care, while contributing to medical research. However, risks may include side effects, unpredictable outcomes, and time commitment. Careful assessment of these factors helps patients make informed decisions. The content of this material, including graphics, images and text, is provided for informational purposes only and does not constitute medical advice, diagnosis or treatment. Please consult your healthcare professional for medical advice. The patient advocate has provided their consent for the use and distribution of this content.
